Table 4.
Other risk factors* | Age | Patient numbers† | ||
60 years | 65 years | 70 years | ||
Lung fibrosis | 37.5 | 40.4 | 43.3 | 131/666 |
Lung fibrosis and CRP elevation | 52.0 | 55.0 | 57.9 | 47/650 |
Active DU | 30.9 | 33.5 | 36.1 | 126/697 |
Lung fibrosis and active DU | 49.7 | 52.6 | 55.6 | 31/662 |
Muscle weakness | 30.9 | 33.5 | 36.2 | 164/701 |
Lung fibrosis, muscle weakness and active DU | 61.8 | 64.6 | 67.3 | 16/660 |
Lung fibrosis, muscle weakness, CRP elevation and active DU |
74.5 | 76.7 | 78.8 | 8/646 |
*Predictors not specified in each row are set to zero.
†Patient numbers irrespective of age that fulfil the criteria within the whole study population.
CRP, C-reactive protein; DU, digital ulcer.